Yükleniyor... / Loading...
This multicenter study collects and follows the clinical data of people who carry a disease-causing mutation in the BRCA1 or BRCA2 genes through a shared platform. It enrolls women aged 18 and older who are known to carry a pathogenic (class 4 or 5) mutation in BRCA1 or BRCA2. It is an observational registry study with no assigned phase and is currently recruiting participants.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * All women who are 18 years of age or older; * All women who known to be carriers of a pathogenetic mutation class 4 and 5 of the International Agency of Research on Cancer classification) of the BRCA1 or BRCA2 genes. Exclusion Criteria: * Age \< 18 years old; * No pathogenetic mutation carriers.